The Investor Globe

  Home   |  Business   |  Personal Finance   |  Gold   |  World   |  USA   |  China   |  India   |  Middle East   |  Bitcoin   |  Techno   |  Blogs   |  M & A   |  IPO

Top Stories on Abilify

What Is Abilify (Aripiprazole) - Medical News Today

Abilify (aripiprazole), a partial dopamine agonist, is an antipsychotic drug with additional antidepressant qualities. It has been approved for the treatment of schizophrenia, bipolar disorder and depression as an add-on treatment when the main ...

UPDATED: FDA denies Otsuka and Lundbeck's antipsychotic drug - FierceBiotech

U.S. regulators have delayed the potential launch of a once-monthly version of the blockbuster antipsychotic Abilify. Otsuka Pharmaceutical and partner H. Lundbeck broke the bad news today that the FDA handed the companies a complete response ...


The change in U.S. net sales attributed to price was a result of higher average net selling prices for Abilify* (aripiprazole) and Plavix*, partially offset by the reduction in our contractual share of Abilify* net sales. See "-Key Products" for ...

United States schizophrenia drug market becoming increasingly saturated - Transworld News

Abilify (aripiprazole; Bristol-Myers Squibb/Otsuka) is the most commonly used antipsychotic brand for first- and second-line treatment of schizophrenia. In a market where treatment decisions are largely driven by safety profiles, Abilify is crucially ...

Generic rivals choke Bristol-Myers 2Q results - Yahoo Finance

Sales edged up 1 percent to $711 million for schizophrenia and bipolar disorder drug Abilify, now Bristol's top seller. They jumped 71 percent for melanoma drug Yervoy, hitting $162 million, and 27 percent to $290 million for rheumatoid ...

UPDATE 2-Bristol sales and earnings fall as generics take a toll - Reuters India

Sales of schizophrenia drug Abilify edged 1 percent higher to $711 million. Many newer drugs did well, including Baraclude, a treatment for hepatitis B infections, whose sales jumped 22 percent to $357 million. Sales of leukemia drug Sprycel ...

Bristol-Myers Squibb: Don't Miss This Attractive Entry Point -

The company has four drugs - Plavix, Avapro, Sustiva, and Abilify - that will be going generic over the next four years. The first drug to go was Plavix this year in May. This was a challenge for the company considering that the company received $6.6 ...

Generic Plavix Hurts Bristol-Myers - Yahoo Finance

Global sales of Abilify, approved for the treatment of schizophrenia and depression, climbed 1% to $711 million. Sales of cancer drug Erbitux increased 3% to $179 million in the second quarter of 2012. Skin cancer drug Yervoy, approved in the US ...

Blogspot logo    Latest Posts from Marc Faber blog
Blogspot logo    Latest Posts from Henrique Simoes blog
  Latest Posts from Mad Money 
Cramer?s Exec Cut: How stores can be telltale signs of a company?s health
Cramer Remix: It's not a good time to be a company like United Rentals
Cramer's memo to Fed: Consider jobs being wiped out by tech before hiking rates
Cramer's lightning round: GoPro's stock could go higher on 'good holiday season'
1 in 4 Venmo users' actions on the app can be monetized, PayPal CFO says
   Latest Posts from Fast Money
'Ugly correction' coming: Dennis Gartman
Your first trade for Tuesday
Retail terrified by EEM: Pro
Stock Pops & Drops: AOL, FEYE, JOSB & RYAAY
Second leg of bond rally: Pro
 Latest Posts from Bill Cara blog
Tables & Charts for Wednesday, Apr 17th, 2013
Bill Cara's Blog for Apr 17, 2013
Tables & Charts for Tuesday, Apr 16th, 2013
Bill Cara's Blog for Apr 16, 2013
Tables & Charts for Monday, Apr 15th, 2013
logo    Latest Posts from Kirk Report

Warning: MagpieRSS: Failed to parse RSS file. (XML_ERR_NAME_REQUIRED at line 1, column 2) in C:\Inetpub\vhosts\\httpdocs\ on line 414

Warning: array_slice() expects parameter 1 to be array, null given in C:\Inetpub\vhosts\\httpdocs\products-on-the-news.php on line 436

Warning: Invalid argument supplied for foreach() in C:\Inetpub\vhosts\\httpdocs\products-on-the-news.php on line 437
Blogspot logo    Latest Posts from Random Roger
Has The Bear Arrived?
Latest posts at TheMaven
Final Random Thoughts
Markets Don?t Close 4/20 On A High
When Knowing What Will Happen Isn?t Enough

  Business News
  Personal Finance
  World News
  U.S. News
  China News
  India News
  Middle East News

  Mergers and Acquisitions
  IPO (initial Public Offering)
  Bernard Madoff
  Geneal Motors Bankruptcy
  Food prices crisis



                 Copyright Leaderglobe.